Liens rapides
Catégories
Fiches d'information
Les fiches d'information fournissent des informations supplémentaires sur l'industrie mondiale des protéines plasmatiques thérapeutiques.
Publications et présentations
Discover the main highlights of our industry in our latest publications.
Ressources pour les patients
Explorez les ressources de PPTA pour les patients intéressés par les thérapies aux protéines plasmatiques.
Rapports des parties prenantes
Apprenez-en plus en accédant à la collection de rapports de l'industrie.
Actualités et communiqués de presse
Restez au courant de l'actualité et des événements de l'Association.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 16, 2017
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
A recent publication in the Emerging Infectious Diseases journal (published online on June 12, 2017) describes two individuals with bleeding disorders who were diagnosed with sporadic Creutzfeldt-Jakob disease (sCJD) (1). The authors of this scientific report have not established a causal link between the treatment with clotting factors and the development of sporadic CJD and concluded that “the occurrence of these cases may simply reflect a chance event in the context of systematic surveillance for CJD in large populations”.
All
PPTA statements
May 16, 2017
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
A recent publication in the Emerging Infectious Diseases journal (published online on June 12, 2017) describes two individuals with bleeding disorders who were diagnosed with sporadic Creutzfeldt-Jakob disease (sCJD) (1). The authors of this scientific report have not established a causal link between the treatment with clotting factors and the development of sporadic CJD and concluded that “the occurrence of these cases may simply reflect a chance event in the context of systematic surveillance for CJD in large populations”.
All
PPTA statements
Mar 1, 2017
The Source - Spring 2017
Magazine of the plasma protein therapeutics industry - Spring 2017
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd52198ee4f33b3aa563_TheSource_Spring2017.pdf
Mar 1, 2017
The Source - Spring 2017
Magazine of the plasma protein therapeutics industry - Spring 2017
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd52198ee4f33b3aa563_TheSource_Spring2017.pdf
Dec 1, 2016
The Source Winter 2016
Magazine of the plasma protein therapeutics industry - Winter 2016
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd78408daf6749d0fd49_TheSource_Winter2016_web.pdf
Dec 1, 2016
The Source Winter 2016
Magazine of the plasma protein therapeutics industry - Winter 2016
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd78408daf6749d0fd49_TheSource_Winter2016_web.pdf
Oct 3, 2016
Zika Virus and Plasma Protein Therapies
Recent scientific and public press reports have heightened awareness of the emergence of Zika virus (ZIKV) in the Americas and the causal relationship between prenatal ZIKV infection and microcephaly and other severe fetal brain defects.
All
PPTA statements
Oct 3, 2016
Zika Virus and Plasma Protein Therapies
Recent scientific and public press reports have heightened awareness of the emergence of Zika virus (ZIKV) in the Americas and the causal relationship between prenatal ZIKV infection and microcephaly and other severe fetal brain defects.
All
PPTA statements
Aucun résultat n'a été trouvé